Finance

Beta
Lists
MOC:WSE
Molecure SA
PLN 5.68
+0.18%
(+0.0100) 1D
Jun 18, 5:00:01 PM GMT+2  ·   PLN
All symbols
SymbolPriceChange% Change
Generating top insights for MOC...
Open
PLN 5.60
High
PLN 5.77
Low
PLN 5.49
Mkt. cap
140.43M
Avg. vol.
39.68K
Volume
11.23K
52-wk high
PLN 9.06
52-wk low
PLN 4.98
EPS
-PLN 0.71
Shares outstanding
24.72M
No. of employees
45
Open
PLN 5.60
High
PLN 5.77
Low
PLN 5.49
Mkt. cap
140.43M
Avg. vol.
39.68K
Volume
11.23K
52-wk high
PLN 9.06
52-wk low
PLN 4.98
EPS
-PLN 0.71
Shares outstanding
24.72M
No. of employees
45
News stories
From sources across the web
About Molecure SA
CEOMarcin Jan Szumowski
Employees45
Founded2012
Headquarters-
SectorPharmaceutical industry
Websitemolecure.com
Last report
Mar 10, 2026
Fiscal period
Q4 2025
EPS / Est. (PLN)
- / -
Revenue / Est. (PLN)
6.52M / 300.00K
+2,073.15%beat
Fiscal Q4 2025 earnings call
Waiting for the earnings call
At a glance
Insights from the latest news and reports
Previous reportsAll values in PLN
Loading Previous Earnings...
Income statement
Revenue
Net income
All values in PLN
Mar 2025
Jun 2025
Sep 2025
Dec 2025
Revenue
597.71K
2.91M
214.80K
2.95M
Cost of goods sold
686.50K
320.70K
362.37K
21.71M
Cost of revenue
686.50K
320.70K
362.37K
21.71M
Research and development expenses
-
-
-
-
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
4.44M
5.51M
4.48M
-14.43M
Operating expense
5.46M
6.34M
5.30M
-16.96M
Total operating expenses
6.15M
6.66M
5.66M
4.75M
Operating income
-5.55M
-3.76M
-5.45M
-1.81M
Other non operating income
-9.26K
78.13K
-
801.03K
EBT including unusual items
-5.18M
-3.51M
-5.27M
-1.73M
EBT excluding unusual items
-5.18M
-3.51M
-5.27M
-1.73M
Income tax expense
-
-
-
-
Effective tax rate
-
-
-
-
Other operating expenses
244.40K
16.14K
75.87K
-191.15K
Net income
-5.18M
-3.51M
-5.27M
-1.73M
Net profit margin
-867.43%
-120.74%
-2,451.83%
-58.66%
Earnings per share
-
-
-
-
Interest and investment income
399.36K
200.50K
212.00K
40.09K
Interest expense
-5.15K
-14.54K
-30.99K
-811.85K
Net interest expenses
394.20K
185.96K
181.01K
-771.76K
Depreciation and amortization charges
777.57K
811.92K
745.28K
-2.33M
EBITDA
-5.31M
-3.52M
-5.22M
-1.58M
Gain or loss from assets sale
-
-18.95K
-39.50K
58.44K
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer

Research

AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer